Höfler, M.: Statistics for mental health care research. Acta Psychiatrica Scandinavica 107 (1), S. 79 - 79 (2003)

Höfler, M.; Wittchen, H. U.; Lieb, R.; Hoyer, J.; Friis, R. H.: Association chain graphs: modelling etiological pathways. International Journal of Methods in Psychiatric Research 12 (2), S. 77 - 84 (2003)

Holsboer, F.: Corticotropin-releasing hormone modulators and depression. Current Opinion in Investigational Drugs 4 (1), S. 46 - 50 (2003)

Holsboer, F.: The role of peptides in treatment of psychiatric disorders. Journal of Neural Transmission-Supplement (64), S. 17 - 34 (2003)

Holsboer, F.: High-Quality Antidepressant Discovery by Understanding Stress Hormone Physiology. Annals of the New York Academy of Sciences 1007, S. 394 - 404 (2003)

Ising, M.: CFA as a method for genetic association studies in complex diseases. Psychology Science 45 (2), S. 236 - 240 (2003)

Janke, W.; Ising, M.: Prediction of placebo responses by multiple regression methods and CFA. Re-analysis of an experiment conducted by W. Janke between 1963 and 1966. Psychology Science 45 (2), S. 223 - 235 (2003)

Keck, M. E.: Neurobiologische Grundlagen des therapeutischen Einsatzes der repetitiven transkraniellen Magnetstimulation (rTMS) in der Psychiatrie. Nervenheilkunde 22, S. 253 - 260 (2003)

Keck, M. E.: Repetitive transkranielle Magnetstimulation (rTMS). Medizinische Monatsschrift für Pharmazeuten 26 (7), S. 227 - 231 (2003)

Keck, M. E.; Welt, T.; Erhardt, A.; Müller, M. B.; Sillaber, I.: Neuroendokrine Effekte der repetitiven transkraniellen Magnetstimulation. Fokus auf Dopamin und Vasopressin. Nervenheilkunde 22 (7), S. 346 - 349 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Landgraf, R.; Holsboer, F.: The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Pharmacopsychiatry 36 (1), S. 27 - 31 (2003)

Kellner, M.; Yassouridis, A.; Hübner, R.; Baker, D. G.; Wiedemann, K.: Endocrine and cardiovascular responses to corticotropin-releasing hormone in patients with posttraumatic stress disorder: A role for atrial natriuretic peptide? Neuropsychobiology 47 (2), S. 102 - 108 (2003)

Korali, Z.; Wittchen, H.; Pfister, H.; Höfler, M.; Oefelein, W.; Stalla, G.: Are patients with pituitary adenomas at an increased risk of mental disorders? Acta Psychiatrica Scandinavica 107 (1), S. 60 - 68 (2003)

Landgraf, R.: Neurobiologie und Genetik der Angst im Tiermodell. Nervenarzt 74, S. 274 - 278 (2003)

Lieb, R.; Schreier, A.; Pfister, H.; Wittchen, H.-U.: Maternal smoking and smoking in adolescents: a prospective community study of adolescents and their mothers. European Addiction Research 9, S. 120 - 130 (2003)

Littleton, J.; Zieglgänsberger, W.: Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. The American Journal on Addictions 12 (Suppl 1), S. S3 - S11 (2003)

Lu, J.; Goula, D.; Sousa, N.; Almeida, O. F. X.: Ionotropic and metabotropic glutamate receptor mediation of glucocorticoid-induced apoptosis in hippocampal cells and the neuroprotective role of synaptic N-methyl-D-asparate receptors. Neuroscience 121 (1), S. 123 - 131 (2003)

Marsicano, G.; Cota, D.; Stalla, G. K.; Pasquali, R.; Pagotto, U.; Lutz, B.: Cannabinoids in energy balance and prospectives in the therapy of obesity. Current Medicinal Chemistry. Central Nervous System Agents 3, S. 81 - 87 (2003)

Merikangas, K. R.; Lieb, R.; Wittchen, H. U.; Avenevoli, S.: Family and high-risk studies of social anxiety disorder. Acta Psychiatrica Scandinavica 108 (Suppl. 417), S. 28 - 37 (2003)

Mitev, A.; Darwish, M.; Wolf, S.; Holsboer, F.; Almeida, O. F. X.; Patchev, V.: Gender differences in the regulation of 3α-hydroxysteroid dehydrogenase in rat brain and sensitivity to neurosteroid-mediated stress protection. Neuroscience 120 (2), S. 541 - 549 (2003)